ES2188766T3 - Composicion farmaceutica que contiene lamotrigina. - Google Patents

Composicion farmaceutica que contiene lamotrigina.

Info

Publication number
ES2188766T3
ES2188766T3 ES96923914T ES96923914T ES2188766T3 ES 2188766 T3 ES2188766 T3 ES 2188766T3 ES 96923914 T ES96923914 T ES 96923914T ES 96923914 T ES96923914 T ES 96923914T ES 2188766 T3 ES2188766 T3 ES 2188766T3
Authority
ES
Spain
Prior art keywords
pct
pharmaceutical composition
composition containing
lamotrigine
containing lamotrigine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96923914T
Other languages
English (en)
Inventor
Alison Green Floyd
Sunil Jain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Application granted granted Critical
Publication of ES2188766T3 publication Critical patent/ES2188766T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UNA FORMULA LIOFILIZADA DE LAMOTRIGINE PREPARADA AL LIOFILIZAR UNA SOLUCION ACUOSA ESTERIL CONGELADA DE LAMOTRIGINE MESILATO CUYO PH ESTA COMPRENDIDO ENTRE 2,5 Y 4.
ES96923914T 1995-06-23 1996-06-20 Composicion farmaceutica que contiene lamotrigina. Expired - Lifetime ES2188766T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9512854.2A GB9512854D0 (en) 1995-06-23 1995-06-23 Novel formulation

Publications (1)

Publication Number Publication Date
ES2188766T3 true ES2188766T3 (es) 2003-07-01

Family

ID=10776584

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96923914T Expired - Lifetime ES2188766T3 (es) 1995-06-23 1996-06-20 Composicion farmaceutica que contiene lamotrigina.

Country Status (12)

Country Link
US (1) US5942510A (es)
EP (1) EP0833640B1 (es)
JP (1) JPH11507936A (es)
AT (1) ATE228844T1 (es)
AU (1) AU6415796A (es)
DE (1) DE69625200T2 (es)
DK (1) DK0833640T3 (es)
ES (1) ES2188766T3 (es)
GB (1) GB9512854D0 (es)
PT (1) PT833640E (es)
SI (1) SI0833640T1 (es)
WO (1) WO1997000681A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9512854D0 (en) * 1995-06-23 1995-08-23 Wellcome Found Novel formulation
GB9812413D0 (en) * 1998-06-10 1998-08-05 Glaxo Group Ltd Compound and its use
DE60022333T2 (de) * 1999-04-09 2006-07-06 Euro-Celtique S.A. Natrium kanalblocker zusammensetzungen und deren verwendung
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
WO2002068398A1 (en) * 2001-02-27 2002-09-06 Teva Pharmaceutical Industries Ltd. New crystal forms of lamotrigine and processes for their preparations
IL160523A0 (en) 2001-09-03 2004-07-25 Newron Pharm Spa PHARMACEUTICAL COMPOSITION COMPRISING GABAPENTIN OR AN ANALOGUE THEREOF AND AN alpha-AMINOAMIDE AND ITS ANALGESIC USE
WO2003090693A2 (en) * 2002-04-23 2003-11-06 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition containing lamotrigine particles of defined morphology
DE10327674A1 (de) * 2003-06-20 2005-01-05 Awd.Pharma Gmbh & Co. Kg Injizierbare Darreichungsform von Flupirtin
ATE471147T1 (de) * 2004-09-10 2010-07-15 Newron Pharm Spa Verwendung von (r)-(halogenbenzyloxy)-benzylamino-propanamiden als natrium- und/oder calciumkanal- selektive modulatoren
JP4778053B2 (ja) 2005-07-14 2011-09-21 リセラ，インコーポレイテッド 局所的脂肪組織処置のための徐放性増強脂肪分解処方物
US20120142919A1 (en) * 2006-08-02 2012-06-07 Medichem, S.A. Method for synthesizing lamotrigine
US8486927B2 (en) * 2007-11-09 2013-07-16 Thar Pharmaceuticals Crystalline forms of lamotrigine
US9132084B2 (en) 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
GB2487868B (en) * 2010-01-15 2014-12-10 Neothetics Inc Lyophilized cake formulations
US9597531B2 (en) 2010-11-24 2017-03-21 Neothetics, Inc. Selective, lipophilic, and long-acting beta agonist monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging
CN104940128A (zh) * 2015-05-31 2015-09-30 黑龙江佰彤儿童药物研究有限公司 一种拉莫三嗪口服液体制剂及其制备方法
GB2641294A (en) 2024-05-24 2025-11-26 Novumgen Ltd An orodispersible tablet of Lamotrigine and its process of preparation
US12605388B2 (en) * 2024-09-25 2026-04-21 Azurity Pharmaceuticals Ireland Limited Lamotrigine salts, co-crystals, and compositions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD151309A5 (de) * 1979-06-01 1981-10-14 Wellcome Found Verfahren zur herstellung von substituierten aminotriazinen
US4406888A (en) * 1981-01-09 1983-09-27 Pfizer Inc. Aqueous micellar solutions of levonantradol and N-methyllevonantradol and lyophilic forms thereof for reconstitution
GB8613183D0 (en) * 1986-05-30 1986-07-02 Wellcome Found Triazine salt
US5283067A (en) * 1987-01-30 1994-02-01 Ciba-Geigy Corporation Parenteral suspensions
US5059619A (en) * 1989-06-14 1991-10-22 Quadra Logic Technologies, Inc. Stable freeze-dried polyhematoporphyrin ether/ester
FR2699077B1 (fr) * 1992-12-16 1995-01-13 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de lésions neurologiques liées à des traumatismes.
FR2702148B1 (fr) * 1993-03-05 1995-04-07 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement du neuro-sida.
FR2702149B1 (fr) * 1993-06-03 1995-04-07 Rhone Poulenc Rorer Sa Application de la lamotrigine dans le traitement du neuro-sida.
GB9317146D0 (en) * 1993-08-18 1993-10-06 Wellcome Found Therapeutic combinations
PL178522B1 (pl) * 1993-09-15 2000-05-31 Syntex Inc Krystaliczny, bezwodny związek, mykofenolan mofetylu, kompozycja odpowiednia do sporządzania wodnego preparatu dożylnego, sposób wytwarzania kompozycji odpowiedniej do sporządzania preparatu dożylnego i zestaw użyteczny do sporządzania dożylnego preparatu
GB9424766D0 (en) * 1994-12-07 1995-02-08 Wellcome Found Pharmaceutical composition
GB9426448D0 (en) * 1994-12-30 1995-03-01 Wellcome Found Process
GB9512854D0 (en) * 1995-06-23 1995-08-23 Wellcome Found Novel formulation

Also Published As

Publication number Publication date
GB9512854D0 (en) 1995-08-23
PT833640E (pt) 2003-04-30
DE69625200D1 (de) 2003-01-16
EP0833640A1 (en) 1998-04-08
JPH11507936A (ja) 1999-07-13
ATE228844T1 (de) 2002-12-15
DK0833640T3 (da) 2003-03-24
SI0833640T1 (en) 2003-08-31
WO1997000681A1 (en) 1997-01-09
AU6415796A (en) 1997-01-22
DE69625200T2 (de) 2003-08-21
EP0833640B1 (en) 2002-12-04
US5942510A (en) 1999-08-24

Similar Documents

Publication Publication Date Title
ES2188766T3 (es) Composicion farmaceutica que contiene lamotrigina.
DE69401204D1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
PT948527E (pt) Novos derivados de ciclosporina sua preparacao e composicoes farmaceuticas que os contem
PT979244E (pt) Derivados de ciclosporina, sua preparacao e composicoes farmaceuticas que os contem
EE9800080A (et) (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid
BR9611400A (pt) "agentes antimicobiano de benzoxazina".
ATE234282T1 (de) Polymorphe verbindungen
FI972434A0 (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
BR9609847A (pt) Derivados de N-(4-Benzila-substituída)-2-aminolactam
ATE233246T1 (de) Hydantoinderivate als zwischenprodukte für pharmazeutische wirkstoffe
BR9608472A (pt) Uso de um composto preparação farmacêutica e processo para uso na profilaxa e/ou tratamento de sintomas dispépticos
ES2132383T3 (es) Inhibidores de proteasa hiv.
DK0891341T3 (da) 1,3,4-Oxadiazinderivater samt deres anvendelse som pesticider
FI973184A7 (fi) Kombinaatioterapia HIV-infektiota varten käyttäen HIV-proteaasi-inhibi ittoria indinavir ja käänteistranskriptaasi-inhibiittoria 3TC, mahdoll isesti yhdessä AZT:n, DDI:n tai DDC:n kanssa
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
PT989994E (pt) Derivados de estreptograminas, a sua preparacao e as composicoes que os contem
BR9608038A (pt) Fenilamidinas substituídas compostos que contêm estes medicamentos e processo para sua preparação
DE69910787D1 (de) Neuartige, pharmazeutisch aktive verbindung
ATE190316T1 (de) Peptid-aldehydderivate als antikoagulierende mittel
BR0109252A (pt) Composto, processo para produzir um composto, composição farmacêutica, e, uso de um composto ou de uma composição
ES2166007T3 (es) Procedimiento para la preparacion de antraquinonas sustituidas.
ES2154457T3 (es) Derivados de ciclohexadieno sustituidos con dimetilo.
KR960700053A (ko) 방사선회복제로서 리루졸의 이용(application of riluzole as a radiorestorer)
MX9101421A (es) Composiciones farmaceuticas que comprenden naproxen y sodio de naproxen e hidrocloruro de pseudoefedrina.